The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Sox2 promotes tamoxifen resistance in breast cancer cells
Open accessAbstract
Development of resistance to therapy continues to be a serious clinical problem in breast cancer management. Cancer stem/progenitor cells have been shown to play roles in resistance to chemo‐ and radiotherapy. Here, we examined their role in the development of resistance to the oestrogen receptor antagonist tamoxifen. Tamoxifen‐resistant cells were enriched for stem/progenitors and expressed high levels of the stem cell marker Sox2. Silencing of the SOX2 gene reduced the size of the stem/progenitor cell population and restored sensitivity to tamoxifen. Conversely, ectopic expression of Sox2 reduced tamoxifen sensitivity in vitro and in vivo . Gene expression profiling revealed activation of the Wnt signalling pathway in Sox2‐expressing cells, and inhibition of Wnt signalling sensitized resistant cells to tamoxifen. Examination of patient tumours indicated that Sox2 levels are higher in patients after endocrine therapy failure, and also in the primary tumours of these patients, compared to those of responders. Together, these results suggest that development of tamoxifen resistance is driven by Sox2‐dependent activation of Wnt signalling in cancer stem/progenitor cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Prospective identification of tumorigenic breast cancer cells
Al-Hajj, M., Wicha, M. S., Benito-Hernandez, A., Morrison, S. J., & Clarke, M. F. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0530291100 · Cited by 10,370
Stem cells, cancer, and cancer stem cells
Reya, T., Morrison, S. J., Clarke, M. F., & Weissman, I. L. (2001) · Nature · doi:10.1038/35102167 · Cited by 9,738
Ginestier, C., Hur, M. H., Charafe-Jauffret, E., Monville, F., Dutcher, J., Brown, M., Jacquemier, J., Viens, P., Kleer, C. G., Liu, S., et al. (2007) · Cell Stem Cell · doi:10.1016/j.stem.2007.08.014 · Cited by 4,012
Ben-Porath, I., Thomson, M. W., Carey, V. J., Ge, R., Bell, G. W., Regev, A., & Weinberg, R. A. (2008) · Nature Genetics · doi:10.1038/ng.127 · Cited by 2,523
In vitro propagation and transcriptional profiling of human mammary stem/progenitor cells
Dontu, G., Abdallah, W. M., Foley, J. M., Jackson, K. W., Clarke, M. F., Kawamura, M. J., & Wicha, M. S. (2003) · Genes & Development · doi:10.1101/gad.1061803 · Cited by 2,406
Harvey, J. M., Clark, G. M., Osborne, C. K., & Allred, D. C. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.5.1474 · Cited by 2,056
Intrinsic Resistance of Tumorigenic Breast Cancer Cells to Chemotherapy
Li, X., Lewis, M. T., Huang, J., Gutierrez, C., Osborne, C. K., Wu, M.-F., Hilsenbeck, S. G., Pavlick, A., Zhang, X., Chamness, G. C., et al. (2008) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djn123 · Cited by 1,794
Small molecule–mediated disruption of Wnt-dependent signaling in tissue regeneration and cancer
Chen, B., Dodge, M. E., Tang, W., Lu, J., Ma, Z., Fan, C.-W., Wei, S., Hao, W., Kilgore, J., Williams, N. S., et al. (2009) · Nature Chemical Biology · doi:10.1038/nchembio.137 · Cited by 1,383
The Response of CD24 −/low /CD44 + Breast Cancer–Initiating Cells to Radiation
Phillips, T. M., McBride, W. H., & Pajonk, F. (2006) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djj495 · Cited by 1,309
Charafe-Jauffret, E., Ginestier, C., Iovino, F., Wicinski, J., Cervera, N., Finetti, P., Hur, M.-H., Diebel, M. E., Monville, F., Dutcher, J., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-2741 · Cited by 1,173
Sheridan, C., Kishimoto, H., Fuchs, R. K., Mehrotra, S., Bhat-Nakshatri, P., Turner, C. H., Goulet, R., Badve, S., & Nakshatri, H. (2006) · Breast Cancer Research · doi:10.1186/bcr1610 · Cited by 993
Pece, S., Tosoni, D., Confalonieri, S., Mazzarol, G., Vecchi, M., Ronzoni, S., Bernard, L., Viale, G., Pelicci, P. G., & Di Fiore, P. P. (2010) · Cell · doi:10.1016/j.cell.2009.12.007 · Cited by 947
Endocrine-responsive breast cancer and strategies for combating resistance
Ali, S., & Coombes, R. C. (2002) · Nature Reviews Cancer · doi:10.1038/nrc721 · Cited by 883
A Wnt–Axin2–GSK3β cascade regulates Snail1 activity in breast cancer cells
Yook, J. I., Li, X.-Y., Ota, I., Hu, C., Kim, H. S., Kim, N. H., Cha, S. Y., Ryu, J. K., Choi, Y. J., Kim, J., et al. (2006) · Nature Cell Biology · doi:10.1038/ncb1508 · Cited by 616
WNT/β-catenin mediates radiation resistance of mouse mammary progenitor cells
Woodward, W. A., Chen, M. S., Behbod, F., Alfaro, M. P., Buchholz, T. A., & Rosen, J. M. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0606599104 · Cited by 603
Osborne, C. K., Shou, J., Massarweh, S., & Schiff, R. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.865s.11.2 · Cited by 462
BRCA1 regulates human mammary stem/progenitor cell fate
Liu, S., Ginestier, C., Charafe-Jauffret, E., Foco, H., Kleer, C. G., Merajver, S. D., Dontu, G., & Wicha, M. S. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0711613105 · Cited by 461
Zeng, Y. A., & Nusse, R. (2010) · Cell Stem Cell · doi:10.1016/j.stem.2010.03.020 · Cited by 396
Proffitt, K. D., Madan, B., Ke, Z., Pendharkar, V., Ding, L., Lee, M. A., Hannoush, R. N., & Virshup, D. M. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-2258 · Cited by 382
The Molecular Mechanism Governing the Oncogenic Potential of SOX2 in Breast Cancer
Chen, Y., Shi, L., Zhang, L., Li, R., Liang, J., Yu, W., Sun, L., Yang, X., Wang, Y., Zhang, Y., et al. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m802917200 · Cited by 358
Selective Estrogen-Receptor Modulators and Antihormonal Resistance in Breast Cancer
Jordan, V. C., & O'Malley, B. W. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.11.3886 · Cited by 324
Ayyanan, A., Civenni, G., Ciarloni, L., Morel, C., Mueller, N., Lefort, K., Mandinova, A., Raffoul, W., Fiche, M., Dotto, G. P., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0600065103 · Cited by 294
Sox2: a possible driver of the basal-like phenotype in sporadic breast cancer
Rodriguez-Pinilla, S. M., Sarrio, D., Moreno-Bueno, G., Rodriguez-Gil, Y., Martinez, M. A., Hernandez, L., Hardisson, D., Reis-Filho, J. S., & Palacios, J. (2007) · Modern Pathology · doi:10.1038/modpathol.3800760 · Cited by 242
Jeon, H.-M., Sohn, Y.-W., Oh, S.-Y., Kim, S.-H., Beck, S., Kim, S., & Kim, H. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-3340 · Cited by 206
Chanrion, M., Negre, V., Fontaine, H., Salvetat, N., Bibeau, F., Grogan, G. M., Mauriac, L., Katsaros, D., Molina, F., Theillet, C., et al. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-1833 · Cited by 203
Expression of the embryonic stem cell marker SOX2 in early-stage breast carcinoma
Lengerke, C., Fehm, T., Kurth, R., Neubauer, H., Scheble, V., Müller, F., Schneider, F., Petersen, K., Wallwiener, D., Kanz, L., et al. (2011) · BMC Cancer · doi:10.1186/1471-2407-11-42 · Cited by 194
SOX2 promotes tumorigenesis and increases the anti-apoptotic property of human prostate cancer cell
Jia, X., Li, X., Xu, Y., Zhang, S., Mou, W., Liu, Y., Liu, Y., Lv, D., Liu, C.-H., Tan, X., et al. (2011) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjr002 · Cited by 194
Growth and differentiation of progenitor/stem cells derived from the human mammary gland
Clayton, H., Titley, I., & Vivanco, M. D. (2004) · Experimental Cell Research · doi:10.1016/j.yexcr.2004.03.029 · Cited by 175
Self-citationChen, M. S., Woodward, W. A., Behbod, F., Peddibhotla, S., Alfaro, M. P., Buchholz, T. A., & Rosen, J. M. (2007) · Journal of Cell Science · doi:10.1242/jcs.03348 · Cited by 170
HOXB9, a gene overexpressed in breast cancer, promotes tumorigenicity and lung metastasis
Hayashida, T., Takahashi, F., Chiba, N., Brachtel, E., Takahashi, M., Godin-Heymann, N., Gross, K. W., Vivanco, M. D. M., Wijendran, V., Shioda, T., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0912710107 · Cited by 162
Self-citationForget, M.-A., Turcotte, S., Beauseigle, D., Godin-Ethier, J., Pelletier, S., Martin, J., Tanguay, S., & Lapointe, R. (2007) · British Journal of Cancer · doi:10.1038/sj.bjc.6603579 · Cited by 159
Therapeutic Implications of the Cancer Stem Cell Hypothesis
Diehn, M., Cho, R. W., & Clarke, M. F. (2009) · Seminars in Radiation Oncology · doi:10.1016/j.semradonc.2008.11.002 · Cited by 145
Effects of estrogen on the proportion of stem cells in the breast
Simões, B. M., Piva, M., Iriondo, O., Comaills, V., López-Ruiz, J. A., Zabalza, I., Mieza, J. A., Acinas, O., & Vivanco, M. D. (2010) · Breast Cancer Research and Treatment · doi:10.1007/s10549-010-1169-4 · Cited by 130
Self-citationSarwar, N., Kim, J. S., Jiang, J., Peston, D., Sinnett, H. D., Madden, P. B., Gee, J. M. W., Nicholson, R. I., Lykkesfeldt, A. E., Shousha, S., et al. (2006) · Endocrine Related Cancer · doi:10.1677/erc.1.01123 · Cited by 116
Wang, Y., Dong, J., Li, D., Lai, L., Siwko, S. K., Li, Y., & Liu, M. (2013) · Stem Cells · doi:10.1002/stem.1438 · Cited by 96
Wnt and mammary stem cells: hormones cannot fly wingless
Roarty, K. P., & Rosen, J. M. (2010) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2010.07.004 · Cited by 79
Distinct Roles for Wnt-4 and Wnt-11 During Retinoic Acid-Induced Neuronal Differentiation
Elizalde, C., Campa, V. M., Caro, M., Schlangen, K., Aransay, A. M., Vivanco, M. D., & Kypta, R. M. (2010) · Stem Cells · doi:10.1002/stem.562 · Cited by 59
Self-citationKhalil, S. I., Tan, G. A., Giri, D. D., Zhou, X. K., & Howe, L. R. (2012) · PLoS ONE · doi:10.1371/journal.pone.0033421 · Cited by 49
Vivanco, M. D., Johnson, R. S., Galante, P. E., Hanahan, D., & Yamamoto, K. R. (1995) · The EMBO Journal · doi:10.1002/j.1460-2075.1995.tb07216.x · Cited by 42
Self-citationFunction Follows Form: Defining Mammary Stem Cells
Vivanco, M. D. (2010) · Science Translational Medicine · doi:10.1126/scitranslmed.3001215 · Cited by 17
Self-citation
Cited by
Wnt signaling in breast cancer: biological mechanisms, challenges and opportunities
Xu, X., Zhang, M., Xu, F., & Jiang, S. (2020) · Molecular Cancer · doi:10.1186/s12943-020-01276-5 · Cited by 588
Stem cell programs in cancer initiation, progression, and therapy resistance
Huang, T., Song, X., Xu, D., Tiek, D., Goenka, A., Wu, B., Sastry, N., Hu, B., & Cheng, S.-Y. (2020) · Theranostics · doi:10.7150/thno.41648 · Cited by 524
The role of SOX family members in solid tumours and metastasis
Grimm, D., Bauer, J., Wise, P., Krüger, M., Simonsen, U., Wehland, M., Infanger, M., & Corydon, T. J. (2020) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2019.03.004 · Cited by 487
Therapeutic Implications of Cellular Heterogeneity and Plasticity in Breast Cancer
Brooks, M. D., Burness, M. L., & Wicha, M. S. (2015) · Cell Stem Cell · doi:10.1016/j.stem.2015.08.014 · Cited by 374
Apoptosis Deregulation and the Development of Cancer Multi-Drug Resistance
Neophytou, C. M., Trougakos, I. P., Erin, N., & Papageorgis, P. (2021) · Cancers · doi:10.3390/cancers13174363 · Cited by 371
Metadata
- Authors
- Piva, M., Domenici, G., Iriondo, O., Rábano, M., Simões, B. M., Comaills, V., Barredo, I., López‐Ruiz, J. A., Zabalza, I., Kypta, R., & Vivanco, M. D. M.
- Venue
- EMBO Molecular Medicine
- Published
- 2013-10-31
- Volume
- 6
- Issue
- 1
- Pages
- 66-79
- ISSN
- 1757-4676 (ISSN-L)
- 1757-4684
- OpenAlex
- W2160064770
- Cited by
- 328
- References
- 40
- FWCI
- 11.22
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.